Literature DB >> 12590120

An optimized protocol for metabolome analysis in yeast using direct infusion electrospray mass spectrometry.

Juan I Castrillo1, Andrew Hayes, Shabaz Mohammed, Simon J Gaskell, Stephen G Oliver.   

Abstract

A method for the global analysis of yeast intracellular metabolites, based on electrospray mass spectrometry (ES-MS), has been developed. This has involved the optimization of methods for quenching metabolism in Saccharomyces cerevisiae and extracting the metabolites for analysis by positive-ion electrospray mass spectrometry. The influence of cultivation conditions, sampling, quenching and extraction conditions, concentration step, and storage have all been studied and adapted to allow direct infusion of samples into the mass spectrometer and the acquisition of metabolic profiles with simultaneous detection of more than 25 intracellular metabolites. The method, which can be applied to other micro-organisms and biological systems, may be used for comparative analysis and screening of metabolite profiles of yeast strains and mutants under controlled conditions in order to elucidate gene function via metabolomics. Examples of the application of this analytical strategy to specific yeast strains and single-ORF yeast deletion mutants generated through the EUROFAN programme are presented.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12590120     DOI: 10.1016/s0031-9422(02)00713-6

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  42 in total

Review 1.  Metabolic profiles to define the genome: can we hear the phenotypes?

Authors:  Julian L Griffin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-06-29       Impact factor: 6.237

Review 2.  Microbial metabolomics: replacing trial-and-error by the unbiased selection and ranking of targets.

Authors:  Mariët J van der Werf; Renger H Jellema; Thomas Hankemeier
Journal:  J Ind Microbiol Biotechnol       Date:  2005-05-14       Impact factor: 3.346

3.  Comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry analysis of metabolites in fermenting and respiring yeast cells.

Authors:  Rachel E Mohler; Kenneth M Dombek; Jamin C Hoggard; Elton T Young; Robert E Synovec
Journal:  Anal Chem       Date:  2006-04-15       Impact factor: 6.986

4.  Metabolomics: building on a century of biochemistry to guide human health.

Authors:  J Bruce German; Bruce D Hammock; Steven M Watkins
Journal:  Metabolomics       Date:  2005-03       Impact factor: 4.290

Review 5.  Mass spectrometry-based metabolomics.

Authors:  Katja Dettmer; Pavel A Aronov; Bruce D Hammock
Journal:  Mass Spectrom Rev       Date:  2007 Jan-Feb       Impact factor: 10.946

Review 6.  Biomarkers for neuroAIDS: the widening scope of metabolomics.

Authors:  Gurudutt Pendyala; Elizabeth J Want; William Webb; Gary Siuzdak; Howard S Fox
Journal:  J Neuroimmune Pharmacol       Date:  2006-10-10       Impact factor: 4.147

7.  Cyclic changes in metabolic state during the life of a yeast cell.

Authors:  Benjamin P Tu; Rachel E Mohler; Jessica C Liu; Kenneth M Dombek; Elton T Young; Robert E Synovec; Steven L McKnight
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-16       Impact factor: 11.205

8.  Identification and evaluation of cycling yeast metabolites in two-dimensional comprehensive gas chromatography-time-of-flight-mass spectrometry data.

Authors:  Rachel E Mohler; Benjamin P Tu; Kenneth M Dombek; Jamin C Hoggard; Elton T Young; Robert E Synovec
Journal:  J Chromatogr A       Date:  2007-10-25       Impact factor: 4.759

9.  Highly-parallel metabolomics approaches using LC-MS for pharmaceutical and environmental analysis.

Authors:  Sunil Bajad; Vladimir Shulaev
Journal:  Trends Analyt Chem       Date:  2007-06-01       Impact factor: 12.296

10.  Time-dependent profiling of metabolites from Snf1 mutant and wild type yeast cells.

Authors:  Elizabeth M Humston; Kenneth M Dombek; Jamin C Hoggard; Elton T Young; Robert E Synovec
Journal:  Anal Chem       Date:  2008-10-01       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.